Search Results

There are 24834 results for: content related to: Reply

  1. You have free access to this content
    Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 876–884, H. Ralph Schumacher Jr., John S. Sundy, Robert Terkeltaub, Howard R. Knapp, Scott J. Mellis, Neil Stahl, George D. Yancopoulos, Yuhwen Soo, Shirletta King-Davis, Steven P. Weinstein, Allen R. Radin and 0619 Study Group

    Article first published online : 28 FEB 2012, DOI: 10.1002/art.33412

  2. You have free access to this content
    Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study

    Arthritis Care & Research

    Volume 64, Issue 10, October 2012, Pages: 1462–1470, H. Ralph Schumacher Jr., Robert R. Evans, Kenneth G. Saag, James Clower, William Jennings, Steven P. Weinstein, George D. Yancopoulos, Jian Wang and Robert Terkeltaub

    Article first published online : 27 SEP 2012, DOI: 10.1002/acr.21690

  3. You have free access to this content
    Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies

    Arthritis & Rheumatism

    Volume 58, Issue 8, August 2008, Pages: 2443–2452, Hal M. Hoffman, Martin L. Throne, N. J. Amar, Mohamed Sebai, Alan J. Kivitz, Arthur Kavanaugh, Steven P. Weinstein, Pavel Belomestnov, George D. Yancopoulos, Neil Stahl and Scott J. Mellis

    Article first published online : 30 JUL 2008, DOI: 10.1002/art.23687

  4. Rilonacept—CAPS and Beyond

    Annals of the New York Academy of Sciences

    Volume 1182, Issue 1, December 2009, Pages: 124–134, Neil Stahl, Allen Radin and Scott Mellis

    Article first published online : 10 DEC 2009, DOI: 10.1111/j.1749-6632.2009.05074.x

  5. Safety and Pharmacokinetics of Subcutaneously Administered Rilonacept in Patients With Well-Controlled End-Stage Renal Disease (ESRD)

    The Journal of Clinical Pharmacology

    Volume 50, Issue 7, July 2010, Pages: 835–841, Dr Allen Radin, Dr Thomas Marbury, Mr Greg Osgood and Dr Pavel Belomestnov

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009351882

  6. You have free access to this content
    The need to compare rilonacept against active treatment for prevention of gout flares: Comment on the article by Schumacher et al

    Arthritis & Rheumatism

    Volume 64, Issue 7, July 2012, Pages: 2415–2416, Aryeh M. Abeles

    Article first published online : 26 JUN 2012, DOI: 10.1002/art.34476

  7. You have free access to this content
    Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis

    Arthritis & Rheumatism

    Volume 65, Issue 9, September 2013, Pages: 2486–2496, Daniel J. Lovell, Edward H. Giannini, Andreas O. Reiff, Yukiko Kimura, Suzanne Li, Philip J. Hashkes, Carol A. Wallace, Karen B. Onel, Dirk Foell, Richard Wu, Stephanie Biedermann, Jennifer D. Hamilton and Allen R. Radin

    Article first published online : 26 AUG 2013, DOI: 10.1002/art.38042

  8. You have free access to this content
    A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome

    Arthritis & Rheumatism

    Volume 58, Issue 8, August 2008, Pages: 2432–2442, Raphaela Goldbach-Mansky, Sharukh D. Shroff, Mildred Wilson, Christopher Snyder, Sara Plehn, Beverly Barham, Tuyet-Hang Pham, Frank Pucino, Robert A. Wesley, Joanne H. Papadopoulos, Steven P. Weinstein, Scott J. Mellis and Daniel L. Kastner

    Article first published online : 30 JUL 2008, DOI: 10.1002/art.23620

  9. Interleukin-1 inhibitors for acute gout

    Intervention Review

    The Cochrane Library

    Francisca Sivera, Mihir D Wechalekar, Mariano Andrés, Rachelle Buchbinder and Loreto Carmona

    Published Online : 1 SEP 2014, DOI: 10.1002/14651858.CD009993.pub2

  10. Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis

    Arthritis & Rheumatology

    Volume 66, Issue 9, September 2014, Pages: 2570–2579, Norman T. Ilowite, Kristi Prather, Yuliya Lokhnygina, Laura E. Schanberg, Melissa Elder, Diana Milojevic, James W. Verbsky, Steven J. Spalding, Yukiko Kimura, Lisa F. Imundo, Marilynn G. Punaro, David D. Sherry, Stacey E. Tarvin, Lawrence S. Zemel, James D. Birmingham, Beth S. Gottlieb, Michael L. Miller, Kathleen O'Neil, Natasha M. Ruth, Carol A. Wallace, Nora G. Singer and Christy I. Sandborg

    Article first published online : 26 AUG 2014, DOI: 10.1002/art.38699

  11. Interventions for reducing inflammation in familial Mediterranean fever

    Intervention Review

    The Cochrane Library

    Bin Wu, Ting Xu, Youping Li and Xi Yin

    Published Online : 20 MAR 2015, DOI: 10.1002/14651858.CD010893.pub2

  12. You have free access to this content
    Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis

    The Journal of Clinical Pharmacology

    Volume 55, Issue 1, January 2015, Pages: 39–44, Julie Autmizguine, Michael Cohen-Wolkowiez, Norman Ilowite and for the RAPPORT investigators

    Article first published online : 22 AUG 2014, DOI: 10.1002/jcph.372

  13. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Article first published online : 11 OCT 2012, DOI: 10.1002/art.37735

  14. Role of Interleukin-1 Inhibitors in the Management of Gout

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 7, July 2013, Pages: 744–753, Tran H. Tran, Jacqueline T. Pham, Hira Shafeeq, Kendra R. Manigault and Vibhuti Arya

    Article first published online : 3 APR 2013, DOI: 10.1002/phar.1265

  15. You have free access to this content
    Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study

    Allergy

    Volume 67, Issue 7, July 2012, Pages: 943–950, K. Krause, K. Weller, R. Stefaniak, H. Wittkowski, S. Altrichter, F. Siebenhaar, T. Zuberbier and M. Maurer

    Article first published online : 15 MAY 2012, DOI: 10.1111/j.1398-9995.2012.02843.x

  16. You have free access to this content
    The emerging role of interleukin-1β in autoinflammatory diseases

    Arthritis & Rheumatism

    Volume 63, Issue 2, February 2011, Pages: 314–324, Helen J. Lachmann, Pierre Quartier, Alexander So and Philip N. Hawkins

    Article first published online : 28 JAN 2011, DOI: 10.1002/art.30105

  17. You have free access to this content
    Rilonacept and canakinumab

    British Journal of Clinical Pharmacology

    Volume 71, Issue 5, May 2011, Pages: 639–641, Eline A. Dubois, Robert Rissmann and Adam F. Cohen

    Article first published online : 11 APR 2011, DOI: 10.1111/j.1365-2125.2011.03958.x

  18. Novel Therapeutics for the Treatment of Familial Mediterranean Fever: From Colchicine to Biologics

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 89–97, I Grattagliano, L Bonfrate, V Ruggiero, G Scaccianoce, G Palasciano and P Portincasa

    Article first published online : 19 DEC 2013, DOI: 10.1038/clpt.2013.148

  19. You have free access to this content
    Interleukin-1 antagonism in acute gout: Is targeting a single cytokine the answer?

    Arthritis & Rheumatism

    Volume 62, Issue 10, October 2010, Pages: 2845–2849, Tuhina Neogi

    Article first published online : 1 JUL 2010, DOI: 10.1002/art.27635

  20. Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS)

    Clinical & Experimental Immunology

    Volume 177, Issue 3, September 2014, Pages: 720–731, M. H. Haverkamp, E. van de Vosse, R. Goldbach-Mansky and S. M. Holland

    Article first published online : 24 JUL 2014, DOI: 10.1111/cei.12361